UK markets closed

Amgen Inc. (0R0T.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
243.76-3.37 (-1.36%)
At close: 06:01PM GMT
Full screen
Previous close247.13
Open245.74
Bid0.00 x 0
Ask0.00 x 0
Day's range245.74 - 246.69
52-week range211.96 - 296.58
Volume2
Avg. volume24,951
Market capN/A
Beta (5Y monthly)0.62
PE ratio (TTM)0.24
EPS (TTM)10.12
Earnings date25 Apr 2024 - 29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE

    Amgen (NASDAQ:AMGN) will host a webcasted call at 1:00 p.m. PT on Thursday, February 22, 2024 to discuss Rare Disease, its newly added fourth pillar of growth, and provide insights on its rare disease strategy and opportunities, including marketed products and pipeline. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen, Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, Vikram Karnani, executive vice president of

  • PR Newswire

    AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

    Amgen (NASDAQ:AMGN) will present at the 34th Annual Oppenheimer Healthcare Life Sciences Conference at 12:00 p.m. ET on Wednesday, Feb. 14, 2024. Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, Murdo Gordon, executive vice president of Global Commerical Operations at Amgen, and Susan Sweeney, senior vice president of Global Marketing, Access and Capabilities at Amgen, will present at the conference. The webcast will be broadcast over the i

  • Yahoo Finance

    GLP-1s: 'We're investing behind this in a big way,' says Amgen CFO

    Amgen is focused on price declines while it looks to fill out its portfolio and chase the new obesity market.